Cadre Holdings, Inc. · Orthopedic, Prosthetic & Surgical Appliances & Supplies

CDRE

Low riskNext report: Nov 4 (confirmed)

View price ↗

The short version

A profitable company with growing sales. Institutions are adding.

Going well

Sales up 32% in the latest quarter vs a year ago
Profitable
Brings in more cash than it spends

Watch out for

Share count growing 6.3% a year

Money moves

No insider buying or selling in the last 30 days
Institutions added 5.4% to their holdings in the quarter ending June 2026 (93 bought, 68 sold)

Facts from SEC filings, not a recommendation.

What the price means

Price as of Oct 26

$30.60+2.1% that day

Company value: $1.3B; Share price times all shares
Price vs profit (P/E): 37.8x; You pay about $38 for each $1 of yearly profit
Price vs sales: 1.9x; Company value is 1.9 times a year of sales
Dividend yield: 0.3%; Yearly dividend as a share of today's price
Cash vs value: 4%; Cash as a share of company value
Debt vs value: 23%; Debt as a share of company value

From CDRE's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.

The business over time

Last 12 quarters, from SEC filings

Sales, Jun '26

$207.1M+32% vs a year earlier

Sep '23Tap a barJun '26

Last 12 months: $685.6M, up 20% from the 12 months before. Over 5 years, sales grew about 8.6% a year.

What the price assumes

Your guesses, our math

Move the sliders to your own view of CDRE. Starting points are the company's recent numbers.

Sales growth+20% a yearRecently: +20% a yearProfit margin5%Last 12 months: 5.3%P/E at the end38xToday: 37.8x. Many steady companies trade at 12x to 25xShare count change+7% a yearBelow zero means buybacks; above zero means new shares (dilution)

Sales in 5 years$1.7B

Profit in 5 years$85M

Price these guesses point to$53.97+76% vs $30.60 todayAbout +12% a year, before dividends

What today's price needs: with a 5% margin and a 38x P/E, sales would have to grow about 7.1% a year for 5 years just to match today's price.

Simple math on your guesses, not a forecast or a price target. Real results depend on many things these sliders leave out.

Price

Price chart by TradingView.

Business quality

The checklist Warren Buffett-style investors use. Annual numbers for 2025.

3/7Mixed

MissReturn on equity 15%+Earns a lot on the money owners have in the business.14.0%
MissDebt under half of equityNot relying on borrowed money.0.97x equity
MissNet margin 10%+Keeps at least 10 cents of profit from each dollar of sales.7.2%
PassProfitable every yearSteady profits, not one good year.6 of 6 years
PassFree cash flow positiveBrings in more cash than it spends to run and grow.$56.8M
MissShare count not growingNot diluting owners. Falling means buybacks.+20.2% in 3 years
PassGross margin 40%+Pricing power: sells for well above what it costs to make.42.5%

Revenue: $610.3M; +7.5% vs prior year
5-year growth: +8.6%/yr; revenue, per year
Total debt: $307.3M; 0.97x equity
Current ratio: 3.50x; short-term assets / bills due

From annual reports filed with the SEC. A checklist is a starting point for research, not a verdict.